Search research articles
Contact Us
Filters
Showing results (171-180 of 192) with videos related to
Page
of 20
Sort By:
The Journal of Thoracic and Cardiovascular Surgery
|
October 10, 2023
Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer
Hope Feldman, Boris Sepesi, Cheuk H Leung, et al.
The Annals of Thoracic Surgery
|
May 19, 2019
Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma
Kyle G Mitchell, Naruhiko Ikoma, David B Nelson, et al.
Journal of Thoracic Disease
|
April 11, 2020
Immune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacities
David B Nelson, Kyle G Mitchell, Jing Wang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 4, 2020
Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively
Erin M Corsini, Qi Wang, Hai T Tran, et al.
Cancer
|
November 28, 2017
Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing
Jacqueline F Wang, Xingxiang Pu, Xiaoshan Zhang, et al.
The Annals of Thoracic Surgery
|
December 9, 2021
Salvage Esophagectomy Definition Influences Comparative Outcomes in Esophageal Squamous Cell Cancers
Nicolas Zhou, Wayne L Hofstetter, , et al.
Frontiers in Oncology
|
August 28, 2023
Radiographic response to neoadjuvant therapy in pleural mesothelioma should serve as a guide for patient selection for cytoreductive operations
Nathaniel Deboever, Nicolas Zhou, Daniel J McGrail, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 17, 2022
Surgical approach does not influence changes in circulating immune cell populations following lung cancer resection
Nathaniel Deboever, Daniel J McGrail, Younghee Lee, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
February 22, 2022
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancer
Boris Sepesi, Nicolas Zhou, William N William, et al.
The European Respiratory Journal
|
July 9, 2016
Defining a standard set of patient-centred outcomes for lung cancer
Kimberley S Mak, Annelotte C M van Bommel, Caleb Stowell, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 192) with videos related to
Sort By:
Page
of 20
The Journal of Thoracic and Cardiovascular Surgery
|
October 10, 2023
Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer
Hope Feldman, Boris Sepesi, Cheuk H Leung, et al.
The Annals of Thoracic Surgery
|
May 19, 2019
Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma
Kyle G Mitchell, Naruhiko Ikoma, David B Nelson, et al.
Journal of Thoracic Disease
|
April 11, 2020
Immune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacities
David B Nelson, Kyle G Mitchell, Jing Wang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 4, 2020
Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively
Erin M Corsini, Qi Wang, Hai T Tran, et al.
Cancer
|
November 28, 2017
Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing
Jacqueline F Wang, Xingxiang Pu, Xiaoshan Zhang, et al.
The Annals of Thoracic Surgery
|
December 9, 2021
Salvage Esophagectomy Definition Influences Comparative Outcomes in Esophageal Squamous Cell Cancers
Nicolas Zhou, Wayne L Hofstetter, , et al.
Frontiers in Oncology
|
August 28, 2023
Radiographic response to neoadjuvant therapy in pleural mesothelioma should serve as a guide for patient selection for cytoreductive operations
Nathaniel Deboever, Nicolas Zhou, Daniel J McGrail, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 17, 2022
Surgical approach does not influence changes in circulating immune cell populations following lung cancer resection
Nathaniel Deboever, Daniel J McGrail, Younghee Lee, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
February 22, 2022
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancer
Boris Sepesi, Nicolas Zhou, William N William, et al.
The European Respiratory Journal
|
July 9, 2016
Defining a standard set of patient-centred outcomes for lung cancer
Kimberley S Mak, Annelotte C M van Bommel, Caleb Stowell, et al.
Page
of 20